Abstract Library

Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.

Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.

ENETS Abstract Search

#2899 Using Long-Acting Somatostatin Analogue as Adjuvant Therapy for Post Resection Grade 2 Pancreatic Neuroendocrine Tumor: Interim Results from an Ongoing Multicenter Real-World Study in China

Introduction: Surgery was the preferred treatment in patients with resectable pancreatic neuroendocrine tumor (pNET), but recurrent lesion relapsed frequently within a short time. It was controversial whether patients with pNET need adjuvant therapy after surgery.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Shi X

Authors: Shi X, Xu X, Zhang Y, Gao S, Li B,

Keywords: somatostatin analogue, adjuvant therapy, pancreatic neuroendocrine tumor,

#2693 The Distinctive Character of Micro-Vasculature and Immune Cell Infiltration in Cystic Pancreatic Neuroendocrine Tumors

Introduction: Hypervascularity is main character of pancreatic neuroendocrine tumors (PanNETs), cystic PanNET (CPanNET) are unique type of PanNETs for which the microenvironment remains unknown.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Gao H,

Keywords: pancreatic neuroendocrine tumors, cystic, microvascular density, microvascular integrity, tumor-associated macrophage,

#2135 Is the Classification of Functioning-PanNET/Non-Functioning PanNET Properly? Insulinoma/Non-Insulinoma Is More Suitable to Distinguish the Clinicopathological and Prognosis Difference of Localized Insulinoma

Introduction: Pancreatic neuroendocrine tumor (PanNET) is classified into Functioning (F-PanNET) and Non-functioning (NF-PanNET) by hormone secretion. But insulinoma is slowly proliferating with unique features compared with Non-insulinoma F-PanNET (NiF-PanNET).

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: yu x

Authors: Gao H, Yu X,

Keywords: pancreatic neuroendocrine tumor, insulinoma, functionality, prognosis, Ki-67,

#1852 Is Ki67 Index in Biopsy Tissue Truly Reflect Grading of Pancreatic Neuroendocrine Neoplasm?

Introduction: Ki67 index is essential for progression and treatment of pancreatic neuroendocrine neoplasm (pNEN). For advanced pNEN patient(pts), Ki67 scoring by core/fine-needle biopsy is used to evaluate pNEN pts’ grade.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: gao H

Authors: Gao H, Jin K, Wang W, Zhang S, Xu J,

Keywords: pNEN, Ki67, biopsy, surgery,

#1385 The Efficiency of Sunitinib in Chinese Patients with Advanced Well-differentiated Pancreatic Neuroendocrine Tumor

Introduction: Systemic therapies for advanced Pancreatic neuroendocrine tumors (pNETs) are various. Sunitinib has shown its efficiency in pNET in clinical trials. While the efficiency of sunitinib in Chinese pNETs has not reported yet.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Gao H

Authors: Gao H, Cheng Y, Bai C,

Keywords: sunitinib, Chinese, pNET, efficiency,